Perfil epidemiológico de la amiloidosis laríngea en el Hospital Militar Central de Bogotá
Abstract
Introduction: Laryngeal amyloidosis is an inflammatory disease characterized by the infiltration of amyloid protein within the extracellular space. It may present as a nodule or as an infiltrative or diffuse laryngeal process. The most common symptoms are dysphonia, dysphagia, dyspnea, and cough. Materials and methods: A descriptive, cross-sectional observational study was conducted. The medical records of patients diagnosed with laryngeal amyloidosis in the Laryngology Department of the Central Military Hospital of Bogotá from 2015 to 2022 were studied. Results: In this cohort, 71.4% of patients presented with dysphonia, while dyspnea and dysphagia were each observed in 14% of patients. Laryngeal stroboscopy revealed that the ventricular bands were the most frequently affected site, followed by the glottis (vocal folds, anterior and posterior commissures). Systemic involvement was identified in 28% of patients. The infiltrative pattern on stroboscopy was observed in 66,6% of patients. Discussion: The findings of this study are consistent with those reported in the largest case series in the literature by Dermody et al. Given the nonspecific presentation of laryngeal amyloidosis, other inflammatory pathologies should be ruled out, including relapsing polychondritis, sarcoidosis; other infectious pathologies such as tuberculous laryngitis, and autoimmune disorders such as multiple myeloma. Conclusions: Although laryngeal amyloidosis is a rare condition, it should be considered in the differential diagnosis of inflammatory laryngeal diseases because of its unfavourable evolution and impact on the quality of life.
Fields of Study & Subjects
Amyloidosis: Diagnosis
Treatment
Outcomes
Voice and Speech Disorders
IgG4-Related and Inflammatory Diseases
Publication details
- Journal / source
- ACTA DE OTORRINOLARINGOLOGÍA & CIRUGÍA DE CABEZA Y CUELLO
- Volume
- 53
- Issue
- 4
- Pages
- 301–307
- Publication date
- 9 February 2026
- Language
- EN